<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0370712</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3660</journal-id>
<journal-id journal-id-type="nlm-ta">Exp Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Neurol.</journal-id>
<journal-title-group>
<journal-title>Experimental neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0014-4886</issn>
<issn pub-type="epub">1090-2430</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29069573</article-id>
<article-id pub-id-type="pmc">5745274</article-id>
<article-id pub-id-type="doi">10.1016/j.expneurol.2017.10.020</article-id>
<article-id pub-id-type="manuscript">NIHMS918205</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sulforaphane restores acetyl-histone H3 binding to Bcl-2 promoter and prevents apoptosis in ethanol-exposed neural crest cells and mouse embryos</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Fuqiang</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xiaopan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Wenke</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Xiaoyang</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Shao-yu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pharmacology and Toxicology, University of Louisville Health Science Center, Louisville, Kentucky 40202, USA</aff>
<aff id="A2">
<label>2</label>University of Louisville Alcohol Research Center, Louisville, Kentucky 40202, USA</aff>
<aff id="A3">
<label>3</label>Department of Reproductive Endocrinology, Zhejiang Provincial People's Hospital, 158 Shangtang Road, Hangzhou, Zhejiang 310014, China</aff>
<aff id="A4">
<label>4</label>Department of Medicine, University of Louisville, Louisville, KY 40292, USA</aff>
<aff id="A5">
<label>5</label>Pediatric Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky 40202, USA</aff>
<aff id="A6">
<label>6</label>Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>To whom correspondence should be sent: Shao-yu Chen, Ph.D., Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40202, Phone: (502) 852-8677, FAX: (502) 852-8927. <email>shaoyu.chen@louisville.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P28">
<bold>Conflict of interest</bold>
</p>
<p id="P29">The authors declare that they have no conflicts of interest with the contents of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>300</volume>
<fpage>60</fpage>
<lpage>66</lpage>
<!--elocation-id from pubmed: 10.1016/j.expneurol.2017.10.020-->
<abstract>
<p id="P1">Sulforaphane (SFN) is an isothiocyanate derived from cruciferous vegetables. SFNâ€™s cytoprotective properties have been demonstrated in several models associated with a variety of disorders. Our recent studies have shown that SFN protects against ethanol-induced oxidative stress and apoptosis in neural crest cells (NCCs), an ethanol-sensitive cell population implicated in Fetal Alcohol Spectrum Disorders (FASD). This study is designed to test the hypothesis that SFN can prevent ethanol-induced apoptosis in NCCs by inhibiting HDAC and increasing histone acetylation at the Bcl-2 promoter. We found that exposure to 50 mM ethanol resulted in a significant increase in HDAC activities in NCCs. Treatment with SFN decreased the activities of HDAC in ethanol-exposed NCCs. We also found that SFN treatment significantly increased the expression of acetyl-histone H3 in NCCs treated with ethanol. ChIP-qPCR assay revealed that ethanol exposure significantly decreased acetyl-histone H3 binding to the Bcl-2 promoter while supplementing with SFN reversed the ethanol-induced reduction in acetyl-histone H3 binding to the Bcl-2 promoter. In addition, SFN treatment restored the expression of Bcl-2 in ethanol-exposed NCCs and diminished ethanol-induced apoptosis in NCCs. Treatment with SFN also significantly diminished apoptosis in mouse embryos exposed to ethanol <italic>in vivo</italic>. These results demonstrate that SFN can epigenetically restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis by increasing histone acetylation at the Bcl-2 promoter and suggest that SFN may prevent FASD through epigenetic regulation of the expression of anti-apoptotic genes.</p>
</abstract>
<kwd-group>
<kwd>Sulforaphane</kwd>
<kwd>ethanol</kwd>
<kwd>apoptosis</kwd>
<kwd>histone deacetylase</kwd>
<kwd>Bcl-2</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>